We are analyzing https://link.springer.com/article/10.1007/s13346-025-01881-1.

Title:
Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategies | Drug Delivery and Translational Research
Description:
Hypertension is a global health challenge associated with significant morbidity and mortality resulting from vascular inflammation and endothelial dysfunction. Chronic hypertension is characterised by endothelial dysfunction, oxidative stress, immune cell recruitment, and cytokine release, all of which exacerbate vascular inflammation. Despite the availability of various antihypertensive therapies, limitations such as drug resistance and suboptimal targeting hinder their efficacy and reveal their side effects. Nanoparticle-based strategies could present innovative solutions by enabling precise drug delivery, minimising off-target effects, and enhancing therapeutic outcomes. Dual-targeting approaches that focus on molecular mechanistic pathways for managing hypertension using nanoparticle-based methods allow targeted modulation of inflammatory pathways as well. This advancement aids in redefining the management of vascular inflammation as a transformative frontier in antihypertensive therapy, addressing the unmet need for targeted, efficient, and patient-tailored treatment strategies. This review outlines the inflammatory pathophysiology underlying vascular hypertension and underscores the necessity of integrating knowledge gaps while inspiring innovative approaches to combat hypertension effectively. It concludes by identifying potential obstacles and solutions to overcome in order to successfully translate such nano-derived therapies into clinical practice applications. Graphical abstract
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

pubmed, article, google, scholar, cas, central, drug, hypertension, delivery, vascular, endothelial, inflammation, nanoparticles, httpsdoiorgs, sci, med, cardiovascular, httpsdoiorg, review, cell, inflammatory, int, rev, treatment, disease, res, zhang, front, mol, therapy, pharmacol, targeted, oxide, dysfunction, targeting, therapeutic, diseases, role, immunol, cells, liu, deliv, mechanisms, applications, atherosclerosis, nat, van, study, nitric, inflammasome,

Topics {✒️}

22483/asset/db3fc274-d276-4b6d-ac76-bd094977914e/assets/graphic/hypertensionaha nm-afgf-loaded peg-nanoliposomes protects 3c00236/asset/images/large/au3c00236_0005 3c00032/asset/images/large/mg3c00032_0004 akt/gsk-3β1/nrf-2 pathway anti-vcam-1 saint-o-somes 2020/asset/images/large/aj-alun210004f001 at1r nox/ros/pp2a pathway pecam-1-targeted micron-sized particles nf-κb/cxcr7-dependent manner deoxycorticosterone acetate/salt-hypertensive mice liposomal-based anti-inflammatory therapy month download article/chapter t-cell-mediated actions tumor necrosis factor-α polymyxin b-modified liposomes polydopamine-assisted silver nanoparticle magnetic-based delivery systems improving nanoparticle-based drug endotoxin-induced pneumonia evaluated radiolabeled asn-gly-arg atorvastatin-loaded pegylated liposome aldosterone-sensitive distal nephron p-glycoprotein efflux pump ultra-sensitive molecular mri marcos-contreras oa endoglin/cd105-based imaging icam-1–directed immunoliposomes specifically antagonizing monocyte-mediated inflammation anti-inflammatory drug candidates nanotechnology-based carrier systems 9600198/asset/images/large/10 hypertensive end-organ damage inflammation-responsive micellar nanoparticles article drug delivery engineering nano-drug biointerface nanoparticle-based approaches nanotechnology-based drug carriers potent anti-inflammatory therapies patient-tailored treatment strategies balloon-dilated atherosclerotic arteries nitric oxide availability nanoparticle-based strategies nanotechnology-enabled health products 1146/annurev-immunol-081022-021207/cite/refworks nanoparticle-mediated delivery endothelium-derived vasoactive mediators nanoparticle-based methods activated endothelial cells p-selectin expression

Questions {❓}

Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases?
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
Role for TNF in atherosclerosis?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategies
         description:Hypertension is a global health challenge associated with significant morbidity and mortality resulting from vascular inflammation and endothelial dysfunction. Chronic hypertension is characterised by endothelial dysfunction, oxidative stress, immune cell recruitment, and cytokine release, all of which exacerbate vascular inflammation. Despite the availability of various antihypertensive therapies, limitations such as drug resistance and suboptimal targeting hinder their efficacy and reveal their side effects. Nanoparticle-based strategies could present innovative solutions by enabling precise drug delivery, minimising off-target effects, and enhancing therapeutic outcomes. Dual-targeting approaches that focus on molecular mechanistic pathways for managing hypertension using nanoparticle-based methods allow targeted modulation of inflammatory pathways as well. This advancement aids in redefining the management of vascular inflammation as a transformative frontier in antihypertensive therapy, addressing the unmet need for targeted, efficient, and patient-tailored treatment strategies. This review outlines the inflammatory pathophysiology underlying vascular hypertension and underscores the necessity of integrating knowledge gaps while inspiring innovative approaches to combat hypertension effectively. It concludes by identifying potential obstacles and solutions to overcome in order to successfully translate such nano-derived therapies into clinical practice applications.
         datePublished:2025-06-10T00:00:00Z
         dateModified:2025-06-10T00:00:00Z
         pageStart:1
         pageEnd:31
         sameAs:https://doi.org/10.1007/s13346-025-01881-1
         keywords:
            Hypertension
            Vascular inflammation
            Nanoparticle-based therapy
            Molecular mechanisms
            Targeted drug delivery
            Pharmaceutical Sciences/Technology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig4_HTML.png
         isPartOf:
            name:Drug Delivery and Translational Research
            issn:
               2190-3948
               2190-393X
            type:
               Periodical
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Althaf Umar K P
               affiliation:
                     name:Amrita Vishwa Vidyapeetham
                     address:
                        name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anagha R. Anil
               affiliation:
                     name:Amrita Vishwa Vidyapeetham
                     address:
                        name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sreeja C. Nair
               url:http://orcid.org/0000-0001-9861-0461
               affiliation:
                     name:Amrita Vishwa Vidyapeetham
                     address:
                        name:Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kanthlal S K
               url:http://orcid.org/0000-0003-2655-846X
               affiliation:
                     name:Sree Krishna College of Pharmacy and Research Center
                     address:
                        name:Department of Pharmacology, Sree Krishna College of Pharmacy and Research Center, Parassala, Thiruvananthapuram, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategies
      description:Hypertension is a global health challenge associated with significant morbidity and mortality resulting from vascular inflammation and endothelial dysfunction. Chronic hypertension is characterised by endothelial dysfunction, oxidative stress, immune cell recruitment, and cytokine release, all of which exacerbate vascular inflammation. Despite the availability of various antihypertensive therapies, limitations such as drug resistance and suboptimal targeting hinder their efficacy and reveal their side effects. Nanoparticle-based strategies could present innovative solutions by enabling precise drug delivery, minimising off-target effects, and enhancing therapeutic outcomes. Dual-targeting approaches that focus on molecular mechanistic pathways for managing hypertension using nanoparticle-based methods allow targeted modulation of inflammatory pathways as well. This advancement aids in redefining the management of vascular inflammation as a transformative frontier in antihypertensive therapy, addressing the unmet need for targeted, efficient, and patient-tailored treatment strategies. This review outlines the inflammatory pathophysiology underlying vascular hypertension and underscores the necessity of integrating knowledge gaps while inspiring innovative approaches to combat hypertension effectively. It concludes by identifying potential obstacles and solutions to overcome in order to successfully translate such nano-derived therapies into clinical practice applications.
      datePublished:2025-06-10T00:00:00Z
      dateModified:2025-06-10T00:00:00Z
      pageStart:1
      pageEnd:31
      sameAs:https://doi.org/10.1007/s13346-025-01881-1
      keywords:
         Hypertension
         Vascular inflammation
         Nanoparticle-based therapy
         Molecular mechanisms
         Targeted drug delivery
         Pharmaceutical Sciences/Technology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13346-025-01881-1/MediaObjects/13346_2025_1881_Fig4_HTML.png
      isPartOf:
         name:Drug Delivery and Translational Research
         issn:
            2190-3948
            2190-393X
         type:
            Periodical
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Althaf Umar K P
            affiliation:
                  name:Amrita Vishwa Vidyapeetham
                  address:
                     name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anagha R. Anil
            affiliation:
                  name:Amrita Vishwa Vidyapeetham
                  address:
                     name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sreeja C. Nair
            url:http://orcid.org/0000-0001-9861-0461
            affiliation:
                  name:Amrita Vishwa Vidyapeetham
                  address:
                     name:Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kanthlal S K
            url:http://orcid.org/0000-0003-2655-846X
            affiliation:
                  name:Sree Krishna College of Pharmacy and Research Center
                  address:
                     name:Department of Pharmacology, Sree Krishna College of Pharmacy and Research Center, Parassala, Thiruvananthapuram, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical"]:
      name:Drug Delivery and Translational Research
      issn:
         2190-3948
         2190-393X
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Amrita Vishwa Vidyapeetham
      address:
         name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
         type:PostalAddress
      name:Amrita Vishwa Vidyapeetham
      address:
         name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
         type:PostalAddress
      name:Amrita Vishwa Vidyapeetham
      address:
         name:Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
         type:PostalAddress
      name:Sree Krishna College of Pharmacy and Research Center
      address:
         name:Department of Pharmacology, Sree Krishna College of Pharmacy and Research Center, Parassala, Thiruvananthapuram, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Althaf Umar K P
      affiliation:
            name:Amrita Vishwa Vidyapeetham
            address:
               name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
               type:PostalAddress
            type:Organization
      name:Anagha R. Anil
      affiliation:
            name:Amrita Vishwa Vidyapeetham
            address:
               name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
               type:PostalAddress
            type:Organization
      name:Sreeja C. Nair
      url:http://orcid.org/0000-0001-9861-0461
      affiliation:
            name:Amrita Vishwa Vidyapeetham
            address:
               name:Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kanthlal S K
      url:http://orcid.org/0000-0003-2655-846X
      affiliation:
            name:Sree Krishna College of Pharmacy and Research Center
            address:
               name:Department of Pharmacology, Sree Krishna College of Pharmacy and Research Center, Parassala, Thiruvananthapuram, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
      name:Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
      name:Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India
      name:Department of Pharmacology, Sree Krishna College of Pharmacy and Research Center, Parassala, Thiruvananthapuram, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(939)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Particles.js
Prism.js

CDN Services {📦}

Crossref
Pbgrd

6.18s.

LINK . SPRINGER . COM {}